StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Revenue from Profit Sharing Arrangements by Quarter

Revenue from Profit Sharing Arrangements ($M)

QuarterlyAnnual

Novartis Revenue from Profit Sharing Arrangements: $391M in Q3 2026, up 10.1% from a year earlier.

Latest, Q3 2026
391
Period ended Sep 30, 2026
Change on a year earlier
+10.1%
355 in Q3 2025
History
17 quarters
Since Q3 2022
Sources
13
Documents cited below

Where the Q3 2026 figure comes from

“|| Profit sharing income | 391 | 355 | 1 179 | 968”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K Note 3 & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRevenue from Profit Sharing Arrangements ($M)Year on yearSource
Q3 2026Sep 30, 2026391+10.1%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026456+28.1%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026332+29.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025373+22.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025355+28.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025356+32.8%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 2025257+20.1%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 2024305+24.5%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024276+10.0%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 2024268+8.9%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 2024214+7.5%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023245-0.8%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 2023251+2.0%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023246–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023199–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022247–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Revenue from Profit Sharing Arrangements ($M), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/collab-profit-sharing

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.